Outline of the natural history of tumours

• Autorzy: Madej J.A.
• Języki publikacji: EN

Abstrakty

EN

The paper presents a historical outline of studies on tumours from prehistoric times (paleo-oncology) to the present, as well as explains how neoplastic processes developed and why they developed only in multicellular organisms (Metazoa). One of such explanations refers to the development of the body’s defence system in the form of a cellular (inflammatory) infiltrate directed both against exopathogens, e.g. viruses, and against neoplastic cells. The paper also discusses the role of the infiltrate in the primary and secondary neoplastic progression and in regression, as well as the influence of exogenous and endogenous factors, including dissipative factors, on tumour development.

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2012
• Tom: 68
• Numer: 05
• Opis fizyczny: p.259-264,fig.,ref.

Twórcy

autor

Madej J.A.

• Chair of Pathology, Department of Pathomorphology and Forensic Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, Norwida 31, 50-375 Wroclaw, Poland

Bibliografia

• 1.Ackerknecht E. H.: Kurze Geschichte der Medizin. Enke Ferlag, Stuttgart 1959.
• 2.Bartnik E., Lorenc A.: Nowotwory a geny. Post. Biol. Kom. Suppl. 2000, 15, 17-25.
• 3.David A. R., Zimmerman M. R.: Cancer: an old disease, a new disease or something in between? Nat. Rev. Cancer 2010, 10, 728-733.
• 4.Don A. A., Hogg P. J.: Mitochondria as cancer drug target. Trends Mol. 2004, 10, 372-378.
• 5.Jasińska A., Krzyżosiak W. J.: BRCA1 i BRCA2 - geny dziedzicznych form raka piersi. Post. Biol. Kom. Suppl. 1998, 10, 25-35.
• 6.Klimek R.: Biology of cancer: thermodynamic answer to some questions. Neuroendocrinol. Lett. 2001, 22, 413-421.
• 7.Klimek R., Madej J. A., Sieroń A.: Rak - nowotwory a choroby nowotworowe. Wyd. R. Klimek, Kraków 2006.
• 8.Madej J. A.: Etiologia i patogeneza nowotworów. Alfa-Medica Press, Bielsko-Biała 1999.
• 9.Mantovani A., Romero P., Palucka A. K., Marincola F. M.: Tumor immunity: effector response to tumor and role of the microenvironment. Lancet 2008, 371, 771-783.
• 10.Michalik M. B. (red.): Kronika Medycyny. Wyd. "Kronika", Warszawa 1994.
• 11.Pellikainen M. J., Pekola T. T., Ropponen K. M.: p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis. J. Clin. Pathol. 2003, 56, 214-220.
• 12.Rehemtulla A.: Dinosaurs and ancient civilizations: reflections on the treatment of cancer. Neoplasia 2010, 957, 957-968.
• 13.Rothschild B. M., Tanke D. H., Helbling M., Martin L. D.: Epidemiologic study of tumors in dinosaurs. Naturwissenschaften 2003, 90, 495-500.
• 14.Rothschild B. M., Witzke B. J., Hershkovitz I.: Metastatic cancer in the Jurassic. Lancet 1999, 354, 398-405.
• 15.Sica A., Allavena P., Mantovani A.: Cancer related inflammation: the macrophage connection. Cancer Lett. 2008, 267, 204-215.
• 16.Stachura J., Domagała W. (red.).: Patologia, znaczy słowo o chorobie. T. I. Patologia ogólna. PAU, Kraków 2003.
• 17.Szlosarek P. W., Balkwill F. R.: Tumour necrosis factor alpha: a potential target for the therapy of solid tumours. Lancet Oncol. 2003, 4, 565-573.
• 18.Thorwald J.: Dawna medycyna jej tajemnice i potęga. Ossolineum, Wrocław 1999.
• 19.Traczyk W. Z., Trzebski A. (red.).: Fizjologia cz³owieka z elementami fizjologii stosowanej i klinicznej. PZWL, Warszawa 2007.
• 20.Willis R. A.: Pathology of Tumors. Butterworths, London 1960.
• 21.Zimmerman M. R.: An experimental study of mummification pertinent to the antiquity of cancer. Cancer 1977, 40, 1358-1362.

Uwagi

Rekord w opracowaniu